UNII 8MDF5V39QO

SODIUM BICARBONATE

Unique Ingredient Identifier 8MDF5V39QO is listed as a ingredient substance
Unii8MDF5V39QO
Preferred Substance NameSODIUM BICARBONATE
Rn144-55-8
Ec205-633-8
NcitC29457
Rxcui36676
Pubchem516892
Molecular FormulaCHO3.Na
InchikeyUIIMBOGNXHQVGW-UHFFFAOYSA-M
Smiles[Na+].OC([O-])=O
Unii TypeINGREDIENT SUBSTANCE
RN144-55-8
EC205-633-8
NCITC29457
RXCUI36676
PUBCHEM516892
MFCHO3.Na
INCHI KEYUIIMBOGNXHQVGW-UHFFFAOYSA-M
SMILES[Na+].OC([O-])=O

Alternate Names

Dosage Forms

UNII 8MDF5V39QO SODIUM BICARBONATE is commonly included in medications in the following forms.

RouteDosage FormPotency
BUCCALGUM7.2 MG
BUCCALGUM, CHEWING25 MG
BUCCALTABLET42 MG
IM - IVINJECTION175 MG/VIAL
IM - IVINJECTION NA
IM - IVPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED ADJPH
IM - IVPOWDER, FOR RECONSTITUTION ADJPH
INTRAMUSCULARINJECTABLE175 mg/1VIAL
INTRAMUSCULARINJECTION3.5 %
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION ADJPH
INTRAPERITONEALPOWDER, FOR INJECTION SOLUTION ADJPH
INTRATHECALINJECTABLE NA
INTRATHECALINJECTION0.005 %
INTRATRACHEALSUSPENSION ADJPH
INTRAVENOUSINJECTABLE175 mg/1VIAL
INTRAVENOUSINJECTION764.66 mg/1VIAL
INTRAVENOUSINJECTION ADJPH
INTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION573.5 mg/1VIAL
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION2.1 %
INTRAVENOUSSOLUTION, INJECTION ADJPH
INTRAVITREALINJECTION0.18 %
IV(INFUSION)INJECTION3.5 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION6 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.18 %
ORALCAPSULE108 MG
ORALCAPSULE, DELAYED ACTION0.36 MG
ORALCAPSULE, HARD GELATIN2 MG
ORALFILM, SOLUBLE0.6 MG
ORALGRANULE, EFFERVESCENT NA
ORALGUM, CHEWING15 MG
ORALPOWDER, FOR SOLUTION87.2 MG/1GM
ORALPOWDER, FOR SUSPENSION NA
ORALSOLUTION NA
ORALSUSPENSION5 MG/5ML
ORALTABLET125 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED4.24 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE140 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, EFFERVESC267 MG
ORALTABLET, COATED9 MG
ORALTABLET, DELAYED ACTION, ENTERIC COATED30 MG
ORALTABLET, DELAYED RELEASE0.43 MG
ORALTABLET, EFFERVESCENT, FOR SOLUTION1600 MG
ORALTABLET, EXTENDED RELEASE40.4 MG
ORALTABLET, FILM COATED40 MG
ORALTABLET, ORALLY DISINTEGRATING30 MG
ORALTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE1 mg
ORALTABLET, SUSTAINED ACTION2.56 MG
ORALTABLET, SUSTAINED ACTION, COATED2.56 MG
SUBCUTANEOUSINJECTION ADJPH
SUBCUTANEOUSPOWDER, FOR INJECTION SOLUTION0.016 %
SUBCUTANEOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED NA
SUBLINGUALTABLET3.25 MG
TRANSDERMALPATCH, ELECTRICALLY CONTROLLED10 MG
VAGINALINSERT43 MG
VAGINALTABLET43 MG

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.